Location History:
- Walnut Creek, CA (US) (2010 - 2015)
- Belmont, CA (US) (2016)
Company Filing History:
Years Active: 2010-2016
Title: Shai Ehrlich: Innovating Treatments for Alopecia and More
Introduction
Shai Ehrlich is a notable inventor based in Walnut Creek, California, recognized for his significant contributions to biomedical research and pharmaceutical innovation. With a total of five patents to his name, Ehrlich has focused his work on developing novel therapeutic approaches to tackle serious health conditions.
Latest Patents
Among his latest innovations, Shai Ehrlich has developed a groundbreaking patent titled "Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure, and other diseases." This invention details a double-stranded compound, specifically an oligoribonucleotide, that down-regulates the expression of the human p53 gene. The patent describes a pharmaceutical composition comprising the oligoribonucleotide compound or a vector capable of expressing it, along with a pharmaceutically acceptable carrier. This invention is particularly relevant for treating patients suffering from alopecia induced by chemotherapy or radiotherapy, especially those diagnosed with certain cancers, including breast cancer.
Career Highlights
Shai Ehrlich currently holds a pivotal position at Quark Pharmaceuticals, Inc., a company dedicated to developing innovative therapeutics to address unmet medical needs. His impactful work in this field showcases a commitment to advancing health solutions and improving patient outcomes.
Collaborations
Throughout his career, Shai Ehrlich has collaborated with esteemed colleagues such as Elena Feinstein and Daniel Zurr. These partnerships highlight the importance of teamwork in driving scientific innovation and bringing novel therapeutic technologies to fruition.
Conclusion
In conclusion, Shai Ehrlich's work represents a significant stride in the treatment of devastating conditions like alopecia and acute renal failure. Through his innovative patents and collaborations at Quark Pharmaceuticals, Ehrlich continues to shape the landscape of modern medicine and emphasizes the power of creativity in addressing health challenges.